Inovio Pharmaceuticals Inc (INO)
9.685
-0.52
(-5.05%)
USD |
NASDAQ |
Apr 19, 15:49
Inovio Pharmaceuticals Price to Book Value: 1.929 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 2.031 |
| April 17, 2024 | 2.205 |
| April 16, 2024 | 1.919 |
| April 15, 2024 | 2.189 |
| April 12, 2024 | 2.197 |
| April 11, 2024 | 2.342 |
| April 10, 2024 | 2.292 |
| April 09, 2024 | 2.316 |
| April 08, 2024 | 2.258 |
| April 05, 2024 | 2.349 |
| April 04, 2024 | 2.380 |
| April 03, 2024 | 2.458 |
| April 02, 2024 | 2.472 |
| April 01, 2024 | 2.613 |
| March 28, 2024 | 2.764 |
| March 27, 2024 | 2.595 |
| March 26, 2024 | 2.466 |
| March 25, 2024 | 2.470 |
| March 22, 2024 | 2.314 |
| March 21, 2024 | 2.187 |
| March 20, 2024 | 2.149 |
| March 19, 2024 | 2.127 |
| March 18, 2024 | 2.135 |
| March 15, 2024 | 2.138 |
| March 14, 2024 | 2.153 |
| Date | Value |
|---|---|
| March 13, 2024 | 2.240 |
| March 12, 2024 | 2.292 |
| March 11, 2024 | 2.398 |
| March 08, 2024 | 2.027 |
| March 07, 2024 | 1.798 |
| March 06, 2024 | 1.966 |
| March 05, 2024 | 1.928 |
| March 04, 2024 | 1.956 |
| March 01, 2024 | 1.902 |
| February 29, 2024 | 1.718 |
| February 28, 2024 | 1.64 |
| February 27, 2024 | 1.749 |
| February 26, 2024 | 1.582 |
| February 23, 2024 | 1.527 |
| February 22, 2024 | 1.485 |
| February 21, 2024 | 1.530 |
| February 20, 2024 | 1.584 |
| February 16, 2024 | 1.537 |
| February 15, 2024 | 1.442 |
| February 14, 2024 | 1.423 |
| February 13, 2024 | 1.266 |
| February 12, 2024 | 1.380 |
| February 09, 2024 | 1.307 |
| February 08, 2024 | 1.113 |
| February 07, 2024 | 1.026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5105
Minimum
Jun 28 2023
565.10
Maximum
Mar 06 2020
12.69
Average
2.982
Median
Jun 03 2019
Price to Book Value Benchmarks
| Cerus Corp | 5.750 |
| Stereotaxis Inc | 12.51 |
| Viemed Healthcare Inc | 2.678 |
| AIM ImmunoTech Inc | 2.462 |
| Protalix BioTherapeutics Inc | 2.437 |
Price to Book Value Related Metrics
| PS Ratio | 258.08 |
| Price | 9.685 |
| Earnings Yield | -62.88% |
| Market Cap | 226.34M |